Literature DB >> 3812751

Purine efflux after cardiac ischemia: relevance to allopurinol cardioprotection.

C M Grum, L H Ketai, C L Myers, M Shlafer.   

Abstract

Allopurinol is thought to protect hearts against damage due to hypoxia or ischemia by inhibiting xanthine oxidase and oxygen radical generation. We subjected isolated rabbit hearts, equilibrated by perfusion at 37 degrees C, to 1 h of global ischemia at 27 or 37 degrees C with or without brief pretreatment with 100 microM allopurinol. The total absence of xanthine or uric acid in the coronary effluent following ischemia, the presence of hypoxanthine (25 +/- 4 microM peak concentration), and the failure of allopurinol to alter purine washout profiles or postischemic cardiac function suggest that rabbit myocardium lacks xanthine oxidase or dehydrogenase. Data obtained with a similar rat heart preparation showed appreciable formation of xanthine (12 +/- 2 microM peak) and uric acid (10 +/- 3 microM). Allopurinol pretreatment inhibited xanthine and uric acid formation and significantly improved key indicators of postischemic left ventricular function. We conclude that there is species dependency in the myocardial activity of xanthine oxidase or dehydrogenase, that when present it can be inhibited by acute allopurinol pretreatment, and that xanthine oxidase activity and its ability to generate oxygen radicals are not universal contributors to cardiac ischemic damage.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3812751     DOI: 10.1152/ajpheart.1987.252.2.H368

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

Review 1.  Inhibition of xanthine oxidase by allopurinol: a therapeutic option for ischaemia induced pathological processes?

Authors:  J G Puig; F A Mateos; V D Diaz
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

Review 2.  Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.

Authors:  Pál Pacher; Alex Nivorozhkin; Csaba Szabó
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

3.  Hydrogen peroxide generation by mitochondria isolated from regionally ischemic and nonischemic dog myocardium.

Authors:  M Shlafer; K P Gallagher; S Adkins
Journal:  Basic Res Cardiol       Date:  1990 Jul-Aug       Impact factor: 17.165

4.  Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury.

Authors:  A S Abd-Elfattah; M E Jessen; J Lekven; A S Wechsler
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

5.  Cardiac endothelial transport and metabolism of adenosine and inosine.

Authors:  L M Schwartz; T R Bukowski; J H Revkin; J B Bassingthwaighte
Journal:  Am J Physiol       Date:  1999-09

6.  Allopurinol-enhanced myocardial protection does not involve xanthine oxidase inhibition or purine salvage.

Authors:  D J Chambers; A Takahashi; S M Humphrey; D M Harvey; D J Hearse
Journal:  Basic Res Cardiol       Date:  1992 May-Jun       Impact factor: 17.165

7.  Allopurinol and reperfusion-induced arrhythmias: increased protection by simultaneous administration of anti-oxidant enzymes.

Authors:  R Crome; A S Manning
Journal:  Cardiovasc Drugs Ther       Date:  1988-09       Impact factor: 3.727

Review 8.  Myocardial ischemia and reperfusion: the role of oxygen radicals in tissue injury.

Authors:  S W Werns; B R Lucchesi
Journal:  Cardiovasc Drugs Ther       Date:  1989-01       Impact factor: 3.727

9.  Gout and the risk for incident heart failure and systolic dysfunction.

Authors:  Eswar Krishnan
Journal:  BMJ Open       Date:  2012-02-15       Impact factor: 2.692

10.  Serum uric acid as an index of impaired renal function in congestive heart failure.

Authors:  Yu Tian; Ying Chen; Bao Deng; Gang Liu; Zhen-Guo Ji; Qing-Zhen Zhao; Yu-Zhi Zhen; Yan-Qiu Gao; Li Tian; Le Wang; Li-Shuang Ji; Guo-Ping Ma; Kun-Shen Liu; Chao Liu
Journal:  J Geriatr Cardiol       Date:  2012-06       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.